 Cerebrospinal fluid neurofilament light, NfL, is a biomarker for neurodegeneration that can also be assessed in blood. Here the authors show in a validation study the potential for plasma NfL as a biomarker for several neurodegenerative diseases. This article was authored by Nicholas J. Ashton, Sharina Janalitz, Ahmed Al-Qlifat, and others.